Why the study?
Identifying the cause of pleural effusion is challenging, making low-cost, minimally invasive, and observer-independent biochemical analyses promising diagnostic tools.
This review highlights the ongoing utility and future potential of biochemical analysis in diagnosing the underlying causes of pleural effusion.
Answers are grounded in this paper and cite their sources.
Reinforces biochemical testing with Light's criteria for pleural effusion workup; leaves open validation of machine learning and molecular diagnostics.
Identifying the cause of pleural effusion is challenging for pulmonologists. Imaging, biopsy, microbiology and biochemical analyses are routinely used for diagnosing pleural effusion. Among these diagnostic tools, biochemical analyses are promising because they have the advantages of low cost, minimal invasiveness, observer independence and short turn-around time. Here, we reviewed the past, present and future of pleural fluid biochemical analysis. We reviewed the history of Light’s criteria and its modifications and the current status of biomarkers for heart failure, malignant pleural effusion, tuberculosis pleural effusion and parapneumonic pleural effusion. In addition, we anticipate the future of pleural fluid biochemical analysis, including the utility of machine learning, molecular diagnosis and high-throughput technologies. Clinical Chemistry and Laboratory Medicine ( CCLM ) should address the topic of pleural fluid biochemical analysis in the future to promote specific knowledge in the laboratory professional community.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: